TempraMed Technologies (FRA:9DY) Scaled Net Operating Assets: -0.47 (As of Mar. 2026)


FRA:9DY TempraMed Technologies Ltd FRA:9DY
1 GF Score
Price €0.30
! 5 Warning Signs
View Full Analysis

What is TempraMed Technologies Scaled Net Operating Assets?

TempraMed Technologies FRA:9DY -14.16% 1 Scaled Net Operating Assets is -0.47 as of Mar. 2026. GuruFocus rates FRA:9DY with a GF Score™ of 1/100. The stock has 5 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TempraMed Technologies's operating assets for the quarter that ended in Mar. 2026 was €1.07 Mil. TempraMed Technologies's operating liabilities for the quarter that ended in Mar. 2026 was €1.80 Mil. TempraMed Technologies's Total Assets for the quarter that ended in Dec. 2025 was €1.57 Mil. Therefore, TempraMed Technologies's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was -0.47.

TempraMed Technologies Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for TempraMed Technologies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TempraMed Technologies Scaled Net Operating Assets Chart

TempraMed Technologies Annual Data
Trend Dec23 Dec24 Dec25
Scaled Net Operating Assets
0.00 0.00 -2.99

TempraMed Technologies Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only 0.00 0.00 -0.55 -0.51 -0.47

FRA:9DY vs ABT, SYK, MDT: Scaled Net Operating Assets Comparison

For the Medical Devices subindustry, TempraMed Technologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TempraMed Technologies Scaled Net Operating Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, TempraMed Technologies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where TempraMed Technologies's Scaled Net Operating Assets falls into.


FRA:9DY
1GF Score
TempraMed Technologies Ltd FRA:9DY
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TempraMed Technologies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TempraMed Technologies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(0.759-2.098)/0.448
=-2.99

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1.573 - 0.814
=0.759

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.175 - 0.39 - 0.687
=2.098

TempraMed Technologies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(1.069-1.802)/1.573
=-0.47

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1.254 - 0.185
=1.069

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2.79 - 0.418 - 0.57
=1.802

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -0.47 mean?
TempraMed Technologies (FRA:9DY) has a Scaled Net Operating Assets of -0.47 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on TempraMed Technologies and its competitors.
Is TempraMed Technologies' Scaled Net Operating Assets too high?
TempraMed Technologies' current Scaled Net Operating Assets is -0.47. Overall, TempraMed Technologies has a GF Score™ of 1/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' Scaled Net Operating Assets compare to ABT and SYK?
TempraMed Technologies' Scaled Net Operating Assets of -0.47 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on TempraMed Technologies and its competitors. TempraMed Technologies's current Scaled Net Operating Assets is -0.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (FRA:9DY) has a current Scaled Net Operating Assets of -0.47. The current Scaled Net Operating Assets is -0.47. TempraMed Technologies' overall GF Score™ is 1/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For TempraMed Technologies (FRA:9DY), the current Scaled Net Operating Assets is -0.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TempraMed Technologies Business Description

Other Exchanges VIVI:Canada
Address Heh B’Iyar 14, Tel-Aviv, ISR, 6209307
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
1GF Score

Get the complete analysis for FRA:9DY

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.30
Price